Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy
Authors
Discussion
Loading...
Member takes
Implication
Clinical review outlines the mechanisms and management of acute graft-versus-host disease in transplant recipients, highlighting the necessity of prompt immunosuppressive therapy.
Key Points
- To review the biologic mechanisms, clinical presentation, prevention strategies, and therapeutic management of acute graft-versus-host disease.
- Synthesized clinical and biologic evidence regarding immune responses following hematopoietic-cell transplantation.
- Acute graft-versus-host disease manifests within three months following hematopoietic-cell transplantation when donor-derived T cells attack host tissues.
- Primary pathological involvement occurs predominantly in the skin, liver, and gastrointestinal tract, managed standardly using immunosuppressive drugs.
Cite This Study
Zeiser et al. (2017) studied this question.